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ADHERENCE TO THERAPY AND QUALITY OF LIFE IN 
HYPERTENSIVE PATIENTS
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SUMMARY – This cross-sectional study aimed to evaluate the association between medication 
adherence and Health-Related Quality of Life (HRQoL) in 120 hypertensive patients. Personal In-
formation Form, SF-36 Quality of Life Scale (SF-36 QoL) and Medication Adherence Self-Efficacy 
Scale (MASES) were used for data collection. Data were analyzed with SPSS program using per-
centage, mean value, standard deviation, significance test of difference between two means, analysis 
of variance, Mann-Whitney U test, Kruskal-Wallis test and χ2-test. MASES and SF-36 QoL scores 
of the patients were found to be low. Adherence to medication and compliance were found to be 
low in males, patients using two or more drugs, and those that did not control their blood pressure 
regularly. In addition, a statistically significant positive relationship was found between adherence 
to medication/compliance, self-efficacy and quality of life (p<0.001). Regular and continuous adap-
tation programs addressing patients on antihypertensive therapy will improve the quality of life of 
these patients. 
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Introduction
Hypertension is a disease which may lead to differ-
ent organ injury and target of life-long hypertension 
therapy is keeping hypertension under control1,2. In 
more than one-half of these patients, blood pressure 
is not under optimal control3. The most often reason 
for this is therapy non-ncompliance4-6. Being able to 
understand, manage and interpret makes the ‘sense of 
compliance’. Sense of compliance is related to inter-
pretation of the current condition. In that case, the 
person can live safely by estimating his own power, 
the events inside and outside, preparing sensations 
and behaviors according to it7. Compliance to therapy 
was found to be influenced by gender, marital status, 
level of education, level of income, and being edu-
cated about hypertension in hypertensive patients8,9. 
Medications used in hypertension treatment are also 
stated to be effective in perceiving the disease and 
compliance9,10.
On the other hand, hypertension impairs the qual-
ity of life (QoL) in advanced stages of the disease and 
shortens life span, although its course is silent at the 
beginning. Hypertensive patients feel the psychology 
of having a chronic disease and have difficulties to 
change their lifestyle; accordingly, there are negative 
effects on QoL. In previous studies, factors like diet 
and exercise were found to have negative effects on 
QoL in hypertensive patients11-13.
Several studies are available in the literature about 
compliance to therapy and QoL in different chronic 
diseases14-18. Different factors affect QoL of hyperten-
sive patients and few studies are available about com-
pliance to therapy and QoL in these patients3,11-13. The 
aim of this study was to determine the relationship 
between adherence to therapy and QoL in hyperten-
sive patients. Therefore, using comparison with the 
existing literature, we investigated the relationship 
between adherence to therapy and QoL and identi-
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fied the factors influencing medication adherence and 
QoL in hypertensive patients.
Patients and Methods
Sample
The study sample included 120 patients aged ≥18, 
treated at the Medicine and Endocrinology Depart-
ments, Cumhuriyet University Hospital, diagnosed 
with hypertension at least three months before, who 
were free from any disorders that could affect their 
cognitive functions and participated in the study on 
voluntary basis. Hypertension, known as high or el-
evated blood pressure, is a condition in which blood 
vessels have persistently raised pressure2,3,5. Normal 
adult blood pressure is defined as blood pressure of 
120 mm Hg when the heart beats (systolic) and blood 
pressure of 80 mm Hg when the heart relaxes (dia-
stolic). When systolic blood pressure is equal to or 
above 140 mm Hg and/or diastolic blood pressure is 
equal to or above 90 mm Hg, the blood pressure is 
considered to be raised or high3,7.
Data collection
After explanations had been given to patients by 
the researcher, data were collected through interviews 
with patients. All patients included in the study filled 
in three data collection tools: Personal Information 
Form (PIF), self-efficacy SF-36 Quality of Life Scale 
(SF-36 QoL) and Medication Adherence Self-Effica-
cy Scale (MASES). 
Personal Information Form. This form was prepared 
by the researchers in the light of information in the 
literature3 for the purpose of determining some socio-
demographic and clinical characteristics of hyperten-
sion patients. The form contains 15 sociodemographic 
and patient history-related questions about patient 
age, gender, marital status, place of residence, edu-
cational status, employment status, occupation, and 
duration of illness. 
Short Form-36 (SF-36). This scale has been used 
in many different languages and cultures to measure 
QoL. The validity and reliability of the Turkish ver-
sion of SF-36 has been reported by Pınar19,20. It is 
composed of simple questions on 8 subscales, includ-
ing physical functioning, social functioning, physi-
cal role limitation, emotional role limitation, bodily 
pain, mental health, vitality, and general health. High 
scores on all SF-36 subscales reflect better QoL, and 
reduction in scores indicates deterioration in QoL. 
The scale was completed by patients under the super-
vision of a physician in order to obtain more accurate 
results21.
Medication Adherence Self-Efficacy Scale (MASES). 
MASES was developed by Ogedegbe  et al.  in 2003 
to measure situation-specific efficacy beliefs regarding 
adherence to prescribed antihypertensive medications 
in a population at a high risk of hypertension-related 
morbidity and mortality22. The MASES is a 26-item, 
patient-derived, self-administered instrument. The 
participants were asked to rate their degree of con-
fidence in taking their blood pressure medication in 
a variety of situations. The response to each item was 
formatted on a three-point Likert scale with 1 = not 
at all sure, 2 = somewhat sure, and 3 = very sure. The 
lowest total score is 26 and the highest is 78. All re-
sponses were added to obtain a summary score with 
higher scores indicating greater self-efficacy. The 
MASES has a Cronbach’s alpha coefficient of 0.92. 
Results of the Cronbach’s alpha and test-retest reli-
ability demonstrate that this MASES is internally 
consistent and yields stable scores over time. The va-
lidity and reliability of the Turkish version of SF-36 
has been reported by Gözüm and Hacihasanoglu. This 
scale is a brief instrument, which is easy for patients to 
use and to understand, taking on average five minutes 
to complete23. For this specific study, the internal reli-
ability coefficient for the MASES was 0.92.
Ethical considerations
Institutional approval was obtained from the 
Cumhuriyet University Medical Sciences Ethics 
Committee. Study aims, plans and benefits were ex-
plained to patients who met the study criteria. Patients 
were asked if they would voluntarily participate in the 
study and their written/oral consents were obtained. 
Confidentiality was maintained at all times. 
Data analysis 
Taking α=0.05 and β=0.10, it was decided that 120 
individuals should have been included in the study. The 
power of p test was 0.90662. Study data were loaded 
on the Statistical Package for Social Sciences (SPSS) 
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for Windows program, version 14.0. Percentage cal-
culation, mean value, test of significance between two 
mean values, χ2-test, one-way analysis of variance, 
Mann-Whitney U test and Kruskal-Wallis test were 
used on data analysis. Data were given in tables us-
ing arithmetic mean and standard deviation. Values of 
p<0.05 were considered statistically significant.
Table 1. Patient characteristics
Characteristic  n (%)
Gender:
   male




   35-54






   hausewife
   retired
   officer






   married




   literate 
   elementary/junior high school
74(61.7)
46 (38.3)
Blood pressure checkups and hyperten-
sion treatment:
   yes
   no 
16 (13.3)
104 (86.7)
Reasons for not performing blood 
pressure checkups and hypertension 
treatment:
   forgetting 
   well-being
104(86.7)
16 (13.3)
Blood pressure value: 
   139/90 mm Hg
   ≥140/90 mm Hg 
56 (46.7)
64 (53.3)
Number of antihypertensive drugs: 
   monotherapy
   polytherapy




Medication adherence self-efficacy scale (MASES) 
(χ±SD) 40.08±5.61
Results
The mean age of study patients was 57.34±8.88 
years, 78.3% were female and more than half (63.3%) 
were housewives, 19.2% were retired and the remain-
ing 11.7% were unemployed, only 61.7% were literate, 
and 63.3% were married.
When patients were questioned about their blood 
pressure and hypertension checkups, 86.7% were 
found not to control their blood pressure and hy-
pertension treatment. The leading cause for this was 
forgetting (86.7%), followed by feeling well (13.3%). 
When blood pressure values were analyzed, blood 
pressure was 140/90 mm Hg and above in more than 
half (53.3%) of patients, and 60% were using only one 
hypertensive drug. MASES scores of the patients were 
low (mean 40.08, SD 5.61). None of the participants 
had received education about hypertension (Table 1).
When compliance to therapy was analyzed accord-
ing to different parameters, compliance was higher in 
women as compared with men, with a statistically sig-
nificant difference (p<0.001). Although the mean val-
ue of compliance was greater among patients aged 55 
and older, the difference was not statistically signifi-
Table 2. Adherence according to some patient character-
istics




   male







   35-54






   married







   monotherapy 





Controls for blood pres-
sure and hypertension 
treatment:
   yes 
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cant. It was also found that compliance was higher in 
patients on monotherapy and controlling their blood 
pressure regularly; this difference was statistically sig-
nificant (p<0.001). Although compliance to therapy 
scores of the single/widow patients was high, the dif-
ference was not statistically significant (Table 2).
On the other hand, while the mean SF-36 score 
was 47.71±8.95, the mean physical field score was 
46.80±9.74 and mental field score 48.38±8.95. In cor-
relation analysis done with the aim of analyzing the 
relationship between compliance to therapy and QoL 
in hypertensive patients, a strongly positive correlation 
was detected between MASES score and mean scores 
obtained on physical health and mental health, the two 
main dimensions of QoL fields (p<0.001). QoL was 
found to increase as compliance to therapy increased.
Discussion
In the present study conducted with the aim of 
analyzing the relationship between compliance to 
therapy and QoL, more than half of the patients were 
female. This is considered to be due to the higher 
prevalence of hypertension among women, thus tak-
ing more place in records24-26. The vast majority of pa-
tients were found to fail to undergo regular checkups 
of blood pressure and hypertensive therapy. Hyper-
tension follow up appears to be inadequate in Tur-
key24, which seems to be explainable by two main rea-
sons: forgetting and feeling well. Advanced age of the 
participants may have contributed to their forgetting 
to take medicine. Similar results were also obtained 
in some previous studies27-30. The role of nurses in pa-
tient education about the importance of regular blood 
pressure control is unquestionable. None of the par-
ticipants was found to have received education about 
hypertension. However, previous studies3,31,32 revealed 
that compliance to therapy and lifestyle changes were 
greater in patients educated about hypertension. In 
the present study, the reason for high blood pressure 
may have been related to the lack of education about 
hypertension. Education and patient awareness are 
important in cases when treatment is to be continued 
at home, as is the case in hypertension. When results 
of the studies about patient education were analyzed, 
it was found to have favorable impact on compliance 
to medication and therapy, along with a decrease in 
blood pressure values5,10,33.
A statistically significant difference was found be-
tween compliance scores of male and female patients, 
i.e. compliance scores were greater in women as com-
pared with men11,12. However, results of some studies 
indicate that compliance was higher in men than in 
women24,34. The reason for this may be the varying 
role of women among communities and different cul-
tural approaches.
When the level of compliance to therapy was 
analyzed according to age distribution, the attitude 
toward antihypertensive medications improved with 
advancing age, although the difference was not statis-
tically significant. While compliance to therapy de-
creased with advancing age in some studies11, others 
report opposite observations12,23. Compliance increas-
ing with age, although statistically nonsignificant, 
may be explained with the individuals becoming more 
responsive, tending to accept the prescribed therapy. 
According to the results of this study, a statistically 
significant difference was found between compliance 
and number of medications. In previous studies, com-
pliance score was found to be higher in patients taking 
only one medication35,36. In the study by Göçgeldi et 
al., the number of antihypertensive drugs was found 
to have negative impact on QoL8. While compli-
ance scores of single/widow patients were higher than 
those of married subjects, the difference did not reach 
statistical significance.
There was no significant difference in compliance 
between patients having regularly undergone blood 
pressure and antihypertensive treatment checkups 
and those that did not. Compliance of patients who 
regularly checked their blood pressure was higher13,37. 
This result could be expected (the lack of statistical 
significance was probably due to the small number of 
study patients) and confirms the need of patient edu-
cation about regular checkups.
The mean mental health score of participants was 
higher than their physical health score. Hyperten-
sion is known to affect physical health more than 
mental health3,8,19. While early signs of hypertension 
are physical, mental symptoms occur in later stages. 
Therefore, it is striking to find that the physical aspect 
of QoL is influenced. Previous studies report similar 
results to ours and the mean QoL score of physical 
health was lower3,8. The study also revealed positive 
correlation between compliance and general health, 
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physical health and mental health. QoL was found to 
increase as compliance increased. 
Low adherence has been proposed as an impor-
tant barrier to achieving hypertension control31,32. The 
exact mechanism through which HRQoL is associ-
ated with medication adherence is unknown; how-
ever, HRQoL appears to be part of a complex web of 
antihypertensive medication adherence characteristics 
which can negatively impact patient ability to man-
age their chronic disease. Previous studies conducted 
among patients with chronic physical diseases have 
linked HRQoL to factors identified as precursors to 
medication adherence, such as patient beliefs that they 
are able to carry out a behavior (self-efficacy)38, patient 
disability and activities of daily living39, their attitudes 
and knowledge about disease treatment40, their per-
ceived level of competence and their overall outlook 
on life (optimism)39,41. Further research is needed to 
understand the mechanisms through which HRQoL 
affects adherence to antihypertensive medications and 
ultimately cardiovascular health. Health care profes-
sionals should consider nonadherence to medication 
when evaluating a patient with poor blood pressure 
control. In selecting an intervention to improve com-
pliance to medications, clinicians should consider en-
gaging the patient in an intervention that overcomes 
the patient-specific barriers. 
In conclusion, adherence to therapy/compliance 
self-efficacy and QoL were found to be low. In ad-
dition, compliance was found to positively influence 
QoL. Risk factors affecting compliance and QoL are 
male sex, age <55, marital status, using two or more 
drugs, and not going for blood pressure checkups. 
Assessment of QoL and compliance is important for 
health care. 
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Sažetak
PRIDRŽAVANJE TERAPIJE I KVALITETA ŽIVOTA HIPERTENZIVNIH BOLESNIKA
M. Mollaoğlu, G. Solmaz  i M. Mollaoğlu 
Cilj ove presječne studije bio je procijeniti udruženost pridržavanja farmakoterapije i kvalitete života povezane sa 
zdravljem (Health-related Quality of Life, HRQoL) kod 120 hipertenzivnih bolesnika. Za prikupljanje podataka rabili su 
se sljedeći alati: Personal Information Form, SF-36 Quality of Life Scale (SF-36 QoL) i Medication Adherence Self-Efficacy 
Scale (MASES). Podaci su analizirani pomoću programa SPSS uz primjenu postotka, testa značajnosti razlike između 
dviju srednjih vrijednosti, analize varijance, Mann-Whitneyjeva U testa, Kruskal-Wallisova testa i χ2-testa. Vrijednosti 
MASES i SF-36 QoL dobivene kod bolesnika bile su niske. Pridržavanje farmakoterapije bilo je nisko kod muškaraca, a 
bolesnici koji su uzimali dva lijeka ili više njih nisu redovito kontrolirali krvni tlak. Uz to, utvrđen je statistički značajan 
pozitivan odnos između pridržavanja farmakoterapije, samostalnog odlučivanja o tome i kvalitete života (p<0,001). Kvali-
tetu života ovih bolesnika može se poboljšati redovnim i trajnim programima prilagodbe usmjerenim ka bolesnicima koji 
uzimaju antihipertenzivne lijekove.
Ključne riječi: Hipertenzija; Farmakoterapija, pridržavanje; Kvaliteta života
